← Open Payments lookup

DAVID HOLT: Open Payments

NPI 1912533589 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$966 in 46 payments from 12 companies in 2025. Trend: 2023 $400 · 2024 $441 · 2025 $966

Food & beverage: $966
CompanyPaymentsAmount
Paratek Pharmaceuticals, Inc.10$212
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$135
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$125
Teva Pharmaceuticals USA, Inc.5$105
Collegium Pharmaceutical, Inc.5$104
PFIZER INC.5$97
Valinor Pharma, LLC3$60
Otsuka America Pharmaceutical, Inc.2$42
Axsome Therapeutics, Inc.1$25
Vanda Pharmaceuticals Inc.1$23

Products named: NUZYRA, CAPLYTA, RELISTOR, AUSTEDO XR, Belbuca, MOVANTIK, XHANCE, OCTAGAM IMMUNE GLOBULIN (HUMAN).

Industry payments across AR — which companies pay providers there.